JBT Marel Q1 revenue beats estimates on protein solutions growth

JBT Marel Corporation

JBT Marel Corporation

JBTM

0.00


Overview

  • US food technology provider's Q1 revenue rose 10% yr/yr, beating analyst expectations

  • Adjusted EPS for Q1 beat consensus

  • Company reiterated full-year 2026 guidance for revenue growth and margin expansion


Outlook

  • JBT Marel reiterates FY 2026 revenue guidance of $3.99 bln to $4.065 bln

  • Company expects FY 2026 adjusted EPS of $8.00 to $8.50

  • JBT Marel anticipates FY 2026 adjusted EBITDA margin of 17.0% to 17.5%


Result Drivers

  • PROTEIN SOLUTIONS GROWTH - Revenue in Protein Solutions rose 22%, aided by higher poultry volume and improvements in meat and fish businesses

  • FOREIGN EXCHANGE IMPACT - Revenue growth included a 6% benefit from foreign exchange translation

  • MARGIN PRESSURE IN PREPARED FOOD & BEVERAGE - Flat revenue and lower margins in Prepared Food and Beverage Solutions due to higher tariffs, lower CPG volume, and warehouse automation challenges


Company press release: ID:nBw5S8V4ma


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Beat

$936 mln

$924.85 mln (5 Analysts)

Q1 Adjusted EPS

Beat

$1.58

$1.48 (5 Analysts)

Q1 EPS

$0.86

Q1 Net Income

$45 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

  • Wall Street's median 12-month price target for JBT Marel Corp is $190.00, about 64.6% above its May 1 closing price of $115.44

  • The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 20 three months ago


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.